Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-30 @ 12:44 PM
Study NCT ID:
NCT01167166
Status:
COMPLETED
Last Update Posted:
2017-06-26
First Post:
2010-07-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL)
Sponsor:
Traws Pharma, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07
Start Date Type:
None
Primary Completion Date:
2013-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-19
First Submit QC Date:
None
Study First Post Date:
2010-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2015-01-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-06-22
Last Update Post Date:
2017-06-26
Last Update Post Date Type:
ACTUAL